Primary lung cancer and extrapulmonary malignancy

Hofmann, Hans-Stefan; Neef, Heinz; Schmidt, Peter
October 2007
European Journal of Cardio-Thoracic Surgery;Oct2007, Vol. 32 Issue 4, p653
Academic Journal
Abstract: Objective: The incidence of second primary malignancies seems to be increasing. The aim of this study was to investigate the incidence, treatment and outcome for patients with second primary lung cancer (SPLC). Methods: Between January 1996 and December 2005, 163 patients with SPLC, occurring after an extrapulmonary malignancy, were recruited by the Tumor Center of Halle (Saale), which represents a region of nearly 1.0 million inhabitants in Germany. The SPLCs were treated under curative aim (n =59), with palliative intend (n =76) or best supportive care (n =28). Results: The incidence of SPLC was 1.6 per 100,000 inhabitants. The localization of the first tumor differed depending on the sex of the patients. The actuarial 5-year survival rate of all patients was 12.7% (median survival time 11.4 months). Univariate analysis revealed treatment strategy as a prognostic factor (p =0.0001). Patients with SPLC having undergone curative treatment turned out to have the best prognosis (median survival: 31.0 months). The Cox proportional hazards model demonstrated that only TNM-staging system was a multivariate and significant independent prognostic predictor for overall survival. The method of surgery, standard lung resection (e.g. lobectomy) versus limited resection had no considerable influence on overall survival (p =0.22), respectively recurrence-free survival (p =0.55). Conclusions: In cases of operability, standard resection must be the method of choice, because of its best survival rates. The results support the demand of an exact and short-term oncological care system to detect early stages of SPLC for patients operated upon for tumors at different sites.


Related Articles

  • The effects of lung resection on physiological motor activity of the oesophagus†. Fiorelli, Alfonso; Vicidomini, Giovanni; Milione, Roberta; Grassi, Roberto; Rotondo, Antonio; Santini, Mario // European Journal of Cardio-Thoracic Surgery;Aug2013, Vol. 44 Issue 2, p250 

    OBJECTIVES To assess the modifications of oesophageal function after major lung resection and whether these modifications are correlated with the extent of resection (pneumonectomy vs others). METHODS In the last 5 years, 40 consecutive surgical patients with lung cancer were prospectively...

  • Pulmonary metastasectomy: Review of experience at a tertiary cancer care center. Deo, Suryanarayana S. V.; Shukla, Nootan Kumar; Khanna, Paras; Jha, Deepak; Pandit, Archit; Thulkar, Sanjay // Journal of Cancer Research & Therapeutics;Jul-Sep2014, Vol. 10 Issue 3, p535 

    Background: Thirty to 40% of all extra thoracic cancers lead to secondary pulmonary lesions and approximately 20% of these cases feature metastases that are confined to the lungs. There is benefit of pulmonary metastasectomy in a select subset of patients. Aims: The goal of this study was to...

  • Type of resection and prognosis in lung cancer. Experience of a multicentre study. Rami-Porta, Ramón; Mateu-Navarro, Miquel; Freixinet, Jordi; de la Torre, Mercedes; José Torres-García, Antonio; Pun, Yat-Wah; Cantó Armengod, Antonio; on behalf of the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S) // European Journal of Cardio-Thoracic Surgery;Oct2005, Vol. 28 Issue 4, p622 

    Abstract: Objective: Analysis of prognosis of the different types of resections for lung cancer defined by the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Methods: From October 1993 to September 1997, 2994 patients with...

  • Evaluation of the 7th edition of the TNM classification for lung cancer at a single institution. Wang, Jia; Wu, Nan; Zheng, Qingfeng; Feng, Yuan; Yan, Shi; Lv, Chao; Li, Shaolei; Wang, Yuzhao; Yang, Yue // Journal of Cancer Research & Clinical Oncology;Jul2014, Vol. 140 Issue 7, p1189 

    Purpose: To assess the utilities and drawbacks of the 7th edition of the TNM classification for lung cancer. Methods: Subjects included 1,469 patients who underwent pulmonary resection for primary non-small cell lung cancer. Survival characteristics were compared using the 6th and 7th editions...

  • Low Perioperative Prealbumin Level Predicts Early Recurrence After Curative Pulmonary Resection for Non-small Cell Lung Cancer. Kawai, Hideki // World Journal of Surgery;Aug2013, Vol. 37 Issue 8, p2006 

    The article offers the author's insights regarding the methods used in the study of curative pulmonary resection to lung cancer.

  • Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes: pooled analysis based on individual patient data. Tanvetyanon, T.; Finley, D. J.; Fabian, T.; Riquet, M.; Voltolini, L.; Kocaturk, C.; Fulp, W. J.; Cerfolio, R. J.; Park, B. J.; Robinson, L. A. // Annals of Oncology;Apr2013, Vol. 24 Issue 4, p889 

    Background Some reports suggest that patients with synchronous multiple foci of nonsmall-cell lung cancers (NSCLC) distributed in multiple lobes have a poor prognosis, even when there is no extrathoracic metastasis. The vast majority of such patients do not receive surgical treatment. For those...

  • Prognostic factors of primary pulmonary mucoepidermoid carcinoma: a clinical and pathological analysis of 34 cases. Li Jiang; Pengfei Li; Zizheng Xiao; Huijuan Qiu; Xinke Zhang; Yongbo Xiao; Bei Zhang // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 10, p6792 

    Pulmonary mucoepidermoid carcinoma (PMEC) is a rare malignant neoplasm, and little is known about the prognostic factors. The aim of the present study was to identify the relationship between tumor's histological features and clinical behaviors and to analyze the survival of patients with PMEC....

  • Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit. Powell, Helen A.; Tata, Laila J.; Baldwin, David R.; Stanley, Rosamund A.; Khakwani, Aamir; Hubbard, Richard B. // Thorax;Sep2013, Vol. 68 Issue 9, p826 

    Introduction: For appropriately staged non-small cell lung cancer (NSCLC) surgical resection can dramatically improve survival, but some may not be offered this treatment because of concerns about perioperative mortality. Methods: We used data from the National Lung Cancer Audit (NLCA) to...

  • Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab. Hellmann, Matthew; Chaft, Jamie; Rusch, Valerie; Ginsberg, Michelle; Finley, David; Kris, Mark; Price, Katharine; Azzoli, Christopher.; Fury, Matthew; Riely, Gregory; Krug, Lee; Downey, Robert; Bains, Manjit; Sima, Camelia; Rizk, Nabil; Travis, William; Rizvi, Naiyer; Paik, Paul // Cancer Chemotherapy & Pharmacology;Aug2013, Vol. 72 Issue 2, p453 

    Purpose: Bevacizumab improves survival in lung adenocarcinomas. The potential anti-tumor benefit of bevacizumab in squamous cell lung cancers (SQCLCs) is unknown because bevacizumab is contraindicated in patients with advanced SQCLC due to an increased risk of hemoptysis. The risk of hemoptysis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics